Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials.
Zinzani PL, Viviani S, Anastasia A, Vitolo U, Luminari S, Zaja F, Corradini P, Spina M, Brusamolino E, Gianni AM, Santoro A, Botto B, Derenzini E, Pellegrini C, Argnani L. Zinzani PL, et al. Among authors: derenzini e. Haematologica. 2013 Aug;98(8):1232-6. doi: 10.3324/haematol.2012.083048. Epub 2013 May 3. Haematologica. 2013. PMID: 23645687 Free PMC article.
Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB-Controlled Oxidative Stress Responses.
Shono Y, Tuckett AZ, Liou HC, Doubrovina E, Derenzini E, Ouk S, Tsai JJ, Smith OM, Levy ER, Kreines FM, Ziegler CG, Scallion MI, Doubrovin M, Heller G, Younes A, O'Reilly RJ, van den Brink MR, Zakrzewski JL. Shono Y, et al. Among authors: derenzini e. Cancer Res. 2016 Jan 15;76(2):377-89. doi: 10.1158/0008-5472.CAN-14-2814. Epub 2016 Jan 7. Cancer Res. 2016. PMID: 26744524 Free PMC article.
RALE051: a novel established cell line of sporadic Burkitt lymphoma.
L'Abbate A, Iacobucci I, Lonoce A, Turchiano A, Ficarra E, Paciello G, Cattina F, Ferrari A, Imbrogno E, Agostinelli C, Zinzani P, Martinelli G, Derenzini E, Storlazzi CT. L'Abbate A, et al. Among authors: derenzini e. Leuk Lymphoma. 2018 May;59(5):1252-1255. doi: 10.1080/10428194.2017.1372580. Epub 2017 Sep 11. Leuk Lymphoma. 2018. PMID: 28893133 No abstract available.
Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patients.
Trino S, Iacobucci I, Erriquez D, Laurenzana I, De Luca L, Ferrari A, Ghelli Luserna Di Rorà A, Papayannidis C, Derenzini E, Simonetti G, Lonetti A, Venturi C, Cattina F, Ottaviani E, Abbenante MC, Russo D, Perini G, Musto P, Martinelli G. Trino S, et al. Among authors: derenzini e. Oncotarget. 2016 Mar 15;7(11):12951-61. doi: 10.18632/oncotarget.7339. Oncotarget. 2016. PMID: 26887044 Free PMC article.
Slow evolution of liver metastasis from colon cancer.
Biasco G, Di Battista M, Derenzini E. Biasco G, et al. Among authors: derenzini e. Dig Liver Dis. 2005 Aug;37(8):628-9. doi: 10.1016/j.dld.2005.04.007. Epub 2005 Apr 26. Dig Liver Dis. 2005. PMID: 15996631 No abstract available.
95 results